Delivery Order 36F79721D0249-36C24826F0187
Award Date 7/1/26
Potential Completion Date 7/31/26
Potential Value $37K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- CSL Behring L.L.C. was awarded a $109,942.20 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. This delivery order is for the provision of Haegard Pharmaceutical products to support healthcare services for veterans in the King of Prussia, Pennsylvania area through September 30th, 2022. No set-aside designation was applied to this...
- The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 8 awarded a $160,099.97 firm fixed price delivery order to CSL Behring L.L.C., a global biotherapeutics company, for emergency pharmacy services. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration, which allows customer agencies to efficiently procure pharmaceuticals through task orders. The...
- The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has...
- This is a firm fixed price purchase order awarded to CSL Behring L.L.C., a global biotherapeutics company, by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The order, valued at $167,215.20, is for the delivery of emergency medication to the King of Prussia, Pennsylvania location. This award was not set aside for any socioeconomic program. CSL Behring provides specialty pharmaceuticals, including Hereditary Angioedema treatment...
- This is a federal contract award made by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, for the delivery of HAEGARDA, a pharmaceutical product used to treat Hereditary Angioedema. The $117,027.68 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has no set-aside designation and...
- The Department of Veterans Affairs Veterans Health Administration awarded a $113,280 delivery order against the CSL Behring L.L.C. Pharmaceuticals and Drugs GSA Schedule to provide HAEGARDA injections for Veterans Integrated Service Network 7. CSL Behring will deliver the medication from its facility in King of Prussia, Pennsylvania to locations within VISN 7 over a three-month period concluding September 30, 2023. The firm fixed price order was awarded without any set aside designations to...
- CSL Behring L.L.C. was awarded a $117,812.76 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. This firm fixed price contract calls for the delivery of 52 units of HAEGARDA INHIBITOR to the place of performance in King of Prussia, Pennsylvania by June 1, 2023. No set-aside designation was used for this award issued under the Master GSA Schedule for...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $154,935.10 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration. The contract is for the supply of the Hereditary Angioedema treatment HAEGARDA and the intravenous...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, for the delivery of blood clotting factors. The $122,855.35 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility in King...
- The Department of Veterans Affairs Veterans Health Administration (VA) awarded a $103,256.12 firm fixed price delivery order to CSL Behring L.L.C. for the supply of HAEGARDA, a C1 inhibitor (human) injection solution, to the VA's Veterans Integrated Service Network 8. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration and the VA. The order has a completion date of December 31, 2018 and did not have...